Carlsmed names Richard Heppenstall CFO, succeeding Leo Greenstein

CARL•2026-09-28

Carlsmed appointed Richard Heppenstall as CFO, effective immediately, succeeding Leo Greenstein, who is leaving to pursue other professional interests. The company reaffirmed its 2026 revenue guidance of $74 million to $78 million.

Carlsmed names Richard Heppenstall CFO, succeeding Leo Greenstein

1. CFO appointment

Related News

Truist Wealth names Caroline Murtaugh regional managing director for Georgia

Silexion says SIL204 uses native serum lipids for cellular uptake, boosts KRAS knockdown in preclinical study

Angi data show Washington, D.C., leads U.S. metros in fall home-maintenance activity

Wall St to open lower as oil spikes after Trump rejects Iran peace proposal

Ondas unit Cyberhawk wins three-year SSE electricity network inspection deal